Panagora Asset Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,166
Closed -$60.7K 1206
2025
Q2
$60.7K Buy
+15,166
New +$37.6K ﹤0.01% 1102

Panagora Asset Management's INZY Position: Q3 2025 in Review

Panagora Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 15,166 shares — an estimated $60.7K sold.

Panagora Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $60.7K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Panagora Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Panagora Asset Management sold 15,166 Inozyme Pharma shares in Q3 2025, an estimated $60.7K.
  • Panagora Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
  • Panagora Asset Management's Inozyme Pharma position peaked at $60.7K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Panagora Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.